Market revenue in 2023 | USD 52.4 million |
Market revenue in 2030 | USD 85.9 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 64.69% in 2023. Horizon Databook has segmented the Norway veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The veterinary API manufacturing market in Norway is expected to witness steady growth in the upcoming decade. The market growth can be attributed to the increasing number of pets. According to the Norwegian Veterinary Institute, dogs and cats are the most popular adopted animals in the country.
Moreover, the government in Norway is undertaking various regulations and initiatives to support the veterinary API market expansion. In addition, the government-funded Norwegian Animal Health Service provides veterinary services and enhances animal health & welfare across the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Norway veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account